These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 24693886

  • 21. Hepatic toxicity possibly associated with kava-containing products--United States, Germany, and Switzerland, 1999-2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 Nov 29; 51(47):1065-7. PubMed ID: 12500906
    [Abstract] [Full Text] [Related]

  • 22. Fulminant liver failure and transplantation after use of dietary supplements.
    Smith RJ, Bertilone C, Robertson AG.
    Med J Aust; 2016 Jan 18; 204(1):30-2. PubMed ID: 26763816
    [No Abstract] [Full Text] [Related]

  • 23. Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound.
    Dastis SN, Rahier J, Lerut J, Geubel AP.
    Eur J Gastroenterol Hepatol; 2007 Nov 18; 19(11):919-22. PubMed ID: 18049158
    [Abstract] [Full Text] [Related]

  • 24. Drug-, herb- and dietary supplement-induced liver injury.
    Cavalieri ML, D'Agostino D.
    Arch Argent Pediatr; 2017 Dec 01; 115(6):e397-e403. PubMed ID: 29087122
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Medical food and food supplements: not always as safe as generally assumed.
    Reichenbach S, Jüni P.
    Ann Intern Med; 2012 Jun 19; 156(12):894-5, W314. PubMed ID: 22711083
    [No Abstract] [Full Text] [Related]

  • 27. Monitoring and managing adverse drug reactions.
    Fincham JE.
    Am Pharm; 1992 Feb 19; NS32(2):74-81. PubMed ID: 1546634
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH, Street DA, O'Neill RK.
    Clin Pharmacol Ther; 2010 Feb 19; 87(2):239-44. PubMed ID: 20032973
    [Abstract] [Full Text] [Related]

  • 30. [Drug-induced liver injury from the dietary supplement Fortodol. A manipulated preparation delayed the diagnosis].
    Kechagias S, Hägg S, Lotfi K.
    Lakartidningen; 2010 Feb 19; 107(4):186-8. PubMed ID: 20333973
    [No Abstract] [Full Text] [Related]

  • 31. Protecting the health of the public--Institute of Medicine recommendations on drug safety.
    Psaty BM, Burke SP.
    N Engl J Med; 2006 Oct 26; 355(17):1753-5. PubMed ID: 17030843
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Black cohosh, safety, and public awareness.
    Dunbar K, Solga SF.
    Liver Int; 2007 Sep 26; 27(7):1017-8. PubMed ID: 17696943
    [No Abstract] [Full Text] [Related]

  • 35. Human factors and medical IT systems: complex incident reporting systems and multiple IV infusions.
    Colvin C, Baird P, Easty T, Trbovich P.
    Biomed Instrum Technol; 2013 Sep 26; Suppl():59-63. PubMed ID: 24111773
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Changes recommended in adverse event reporting on dietary supplements.
    Landis NT.
    Am J Health Syst Pharm; 2001 Jun 01; 58(11):948, 951, 954. PubMed ID: 11402486
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network.
    Ferrajolo C, Coloma PM, Verhamme KM, Schuemie MJ, de Bie S, Gini R, Herings R, Mazzaglia G, Picelli G, Giaquinto C, Scotti L, Avillach P, Pedersen L, Rossi F, Capuano A, van der Lei J, Trifiró G, Sturkenboom MC, EU-ADR consortium.
    Drug Saf; 2014 Feb 01; 37(2):99-108. PubMed ID: 24446276
    [Abstract] [Full Text] [Related]

  • 40. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G, Piccinni C, D'Alessandro R, Poluzzi E.
    Cephalalgia; 2014 Jan 01; 34(1):5-13. PubMed ID: 23921799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.